| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.7326/0003-4819-137-3-200208060-00009 |
| P8608 | Fatcat ID | release_nykdwazrxbhw3hrxn3acl53n5m |
| P3181 | OpenCitations bibliographic resource ID | 455189 |
| P698 | PubMed publication ID | 12160365 |
| P5875 | ResearchGate publication ID | 11226760 |
| P2093 | author name string | Marfin AA | |
| Petersen LR | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | West Nile virus | Q158856 |
| P304 | page(s) | 173-9 | |
| P577 | publication date | 2002-08-06 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | West Nile virus: a primer for the clinician | |
| P478 | volume | 137 |
| Q58842025 | A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya |
| Q27488963 | A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial |
| Q34833926 | A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial |
| Q45363093 | A West Nile virus vaccine |
| Q21245776 | A bird's eye view: using geographic analysis to evaluate the representativeness of corvid indicators for West Nile virus surveillance |
| Q40548382 | A fatal case of West Nile virus infection in a bone marrow transplant recipient |
| Q37036994 | A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). |
| Q25256815 | A human-health risk assessment for West Nile virus and insecticides used in mosquito management |
| Q40266095 | A man who vomited until he couldn't walk |
| Q38992578 | A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases |
| Q40431896 | A prospective evaluation of factors associated with chorioretinitis in patients with West Nile virus infection |
| Q40507551 | A recombinant envelope protein vaccine against West Nile virus |
| Q33982270 | A seroprevalence study of west nile virus infection in solid organ transplant recipients |
| Q27481089 | Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion |
| Q40304256 | Accumulation of ubiquitinated proteins is related to West Nile virus-induced neuronal apoptosis |
| Q24816212 | Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA. |
| Q24594634 | Acute flaccid paralysis and West Nile virus infection |
| Q27472671 | Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival |
| Q56398242 | An Immunopharmacoinformatics Approach in Development of Vaccine and Drug Candidates for West Nile Virus |
| Q36255087 | Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis |
| Q27478055 | Antiviral Peptides Targeting the West Nile Virus Envelope Protein |
| Q35085660 | Antiviral macrophage responses in flavivirus encephalitis |
| Q36353567 | Approach to neuromuscular disorders in the intensive care unit |
| Q38008644 | Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex |
| Q35778817 | Arboviral encephalitides: transmission, emergence, and pathogenesis |
| Q40255394 | Arenavirus and West Nile virus in solid organ transplantation. |
| Q27488847 | Assessment of methods for prediction of human West Nile virus (WNV) disease from WNV-infected dead birds |
| Q40369441 | Backward bifurcation and optimal control in transmission dynamics of west nile virus |
| Q40485132 | Bird-baited traps for surveillance of West Nile mosquito vectors: effect of bird species, trap height, and mosquito escape rates |
| Q34342804 | Breast milk and infection |
| Q35805871 | Calgary experience with West Nile virus neurological syndrome during the late summer of 2003. |
| Q27478369 | Caspase 3-Dependent Cell Death of Neurons Contributes to the Pathogenesis of West Nile Virus Encephalitis |
| Q42998766 | Cerebrospinal fluid cytology in seasonal epidemic West Nile virus meningo-encephalitis. |
| Q39477334 | Chapter 10 Viral infections of lower motor neurons. |
| Q34314429 | Characterization of Rabensburg virus, a flavivirus closely related to West Nile virus of the Japanese encephalitis antigenic group |
| Q40550318 | Chorioretinal lesions in nonfatal cases of West Nile virus infection |
| Q42989925 | Collaborative study to evaluate a working reagent for West Nile virus RNA detection by nucleic acid testing |
| Q40286544 | Current practices and evaluation of screening solid organ donors for West Nile virus |
| Q35847362 | Dead crow density and West Nile virus monitoring, New York |
| Q31119743 | Deadly viral syndrome mimics |
| Q35628958 | Death from the Nile crosses the Atlantic: the West Nile Fever story |
| Q27480964 | Detection of West Nile Virus (WNV)-Specific Immunoglobulin M in a Reference Laboratory Setting during the 2002 WNV Season in the United States |
| Q40489267 | Detection of West Nile virus in the Mexican blood supply |
| Q26314682 | Detection of dengue, west Nile virus, rickettsiosis and leptospirosis by a new real-time PCR strategy |
| Q37737591 | Development and application of lateral flow test strip technology for detection of infectious agents and chemical contaminants: a review |
| Q24570065 | Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors |
| Q40325458 | Development time of IgG antibodies to West Nile virus |
| Q24696561 | Developmental outcomes in young children born to mothers with West Nile illness during pregnancy |
| Q42751669 | Diagnosis and treatment of west nile infections. |
| Q37376398 | Differential virulence and pathogenesis of West Nile viruses |
| Q40551311 | Diplopia: a focal neurologic presentation of West Nile meningoencephalitis |
| Q34502820 | Disease surveillance and the academic, clinical, and public health communities |
| Q50532061 | Dynamics of tissue-specific CD8+ T cell responses during West Nile virus infection. |
| Q37235281 | Ecology of West Nile virus in North America |
| Q40505199 | Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models |
| Q27487482 | Efficacy of Aerial Spraying of Mosquito Adulticide in Reducing Incidence of West Nile Virus, California, 2005 |
| Q40546175 | Electroencephalography findings in adult patients with West Nile virus-associated meningitis and meningoencephalitis |
| Q38695932 | Emergence of West Nile virus in West Bengal, India: a new report |
| Q34650104 | Emergence of west nile virus lineage 2 in europe: a review on the introduction and spread of a mosquito-borne disease |
| Q64089980 | Emergent Arboviruses and Renal Transplantation: A Global Challenge |
| Q33793603 | Emergent infectious uveitis |
| Q27860800 | Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses |
| Q35869024 | Emerging infections in transfusion medicine |
| Q80483273 | Emerging viral infections |
| Q36619721 | Emerging viral infections in transplantation |
| Q92845555 | Environmental and Sociological Factors Associated with the Incidence of West Nile Virus Cases in the Northern San Joaquin Valley of California, 2011-2015 |
| Q30250251 | Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen. |
| Q101409866 | Epidemiological hypothesis testing using a phylogeographic and phylodynamic framework |
| Q40464631 | Eradicating vector-borne diseases via age-structured culling. |
| Q36921042 | Estimating biologically relevant parameters under uncertainty for experimental within-host murine West Nile virus infection. |
| Q38444436 | Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay |
| Q27010636 | Experimental infections of wild birds with West Nile virus |
| Q81584864 | Facts and ideas from anywhere |
| Q42988279 | Fatal West Nile virus encephalitis following autologous peripheral blood stem cell transplantation |
| Q42980585 | Fever and Asymmetrical Weakness in the Summer: Evidence of a West Nile Virus–Associated Poliomyelitis-Like Illness |
| Q40013701 | Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease? |
| Q37765386 | Flavivirus encephalitis: pathological aspects of mouse and other animal models |
| Q56876854 | Flaviviruses |
| Q35120864 | Focal neurological injury caused by West Nile virus infection may occur independent of patient age and premorbid health |
| Q27488301 | Frequency of Missed Cases of Probable Acute West Nile Virus (WNV) Infection when Testing for WNV RNA Alone or WNV Immunoglobulin M Alone |
| Q39626614 | Generation of a recombinant West Nile virus stably expressing the Gaussia luciferase for neutralization assay |
| Q27487086 | Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005 |
| Q40287128 | Glial S100B is elevated in serum across the spectrum of West Nile virus infection |
| Q38642875 | Global research trends in West Nile virus from 1943 to 2016: a bibliometric analysis |
| Q52596435 | High susceptibility of magpie (Pica pica) to experimental infection with lineage 1 and 2 West Nile virus. |
| Q27489722 | IL-10 Signaling Blockade Controls Murine West Nile Virus Infection |
| Q35214362 | Identifying the environmental conditions favouring West Nile Virus outbreaks in Europe |
| Q33584872 | Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery |
| Q42537851 | Imported West Nile virus infection in Europe |
| Q40215993 | Indigenous West Nile virus infections in horses in Albania. |
| Q27472601 | Individual donor nucleic acid amplification testing for detection of West Nile virus |
| Q27489551 | Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway |
| Q35943886 | Induction of the cellular microRNA, Hs_154, by West Nile virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors |
| Q42751700 | Introduction to the west nile virus issue |
| Q27478409 | Investigating the spatial risk distribution of West Nile virus disease in birds and humans in southern Ontario from 2002 to 2005 |
| Q40344429 | Is West Nile virus a potential cause of central nervous system infection in Brazil? |
| Q34448110 | Is initial preservation of deep tendon reflexes in West Nile Virus paralysis a good prognostic sign? |
| Q57103043 | Key Factors Influencing the Incidence of West Nile Virus in Burleigh County, North Dakota |
| Q27490802 | Key role of T cell defects in age-related vulnerability to West Nile virus |
| Q27489367 | Lineage 2 West Nile Virus as Cause of Fatal Neurologic Disease in Horses, South Africa |
| Q27490829 | Localization of West Nile Virus in monkey brain: double staining antigens immunohistochemically of neurons, neuroglia cells and West Nile Virus |
| Q34557857 | Long-term clinical and neuropsychological outcomes of West Nile virus infection |
| Q59350941 | Lymph nodes as barriers to T-cell rejuvenation in aging mice and nonhuman primates |
| Q30145523 | Management of Viral Central Nervous System Infections: A Primer for Clinicians |
| Q36564942 | Manifestations of West Nile neuroinvasive disease |
| Q40537444 | MicroRNA reduction of neuronal West Nile virus replication attenuates and affords a protective immune response in mice |
| Q35883310 | Microarray analysis of gene expression in West Nile virus-infected human retinal pigment epithelium |
| Q38912023 | Misdiagnosis of early Lyme disease as the summer flu |
| Q58805838 | Molecular diagnosis of flaviviruses |
| Q35920649 | Molecular methods for diagnosis of viral encephalitis |
| Q33238490 | Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion |
| Q47556358 | Mosquito-borne arboviruses of African origin: review of key viruses and vectors |
| Q34394947 | Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse model |
| Q40154937 | Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo |
| Q40281592 | Neglected infections of poverty in Texas and the rest of the United States: management and treatment options |
| Q30250931 | Neurodevelopmental Delay Diagnosis Rates Are Increased in a Region with Aerial Pesticide Application |
| Q90705326 | Neuroinvasive West Nile Virus Post-Heart Transplantation: A Case Report |
| Q27488363 | Neurologic Aspects of Infections in International Travelers |
| Q27009096 | Neurological approaches for investigating West Nile virus disease and its treatment in rodents |
| Q40531877 | Neurological manifestations of West Nile virus infection. |
| Q40518678 | Neuromuscular Manifestations of Human West Nile Virus Infection |
| Q40291825 | Neuromuscular manifestations of west nile virus infection |
| Q40378539 | Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection |
| Q40549191 | Neuropathological findings in West Nile virus encephalitis: A case report |
| Q36063273 | Neuropsychological Impact of West Nile Virus Infection: An Extensive Neuropsychiatric Assessment of 49 Cases in Canada |
| Q37739804 | No evidence of West Nile virus infection among Polish patients with encephalitis |
| Q37587768 | Novel infectious agents causing uveitis |
| Q40436188 | Occlusive retinal vasculitis in a patient with West Nile virus |
| Q40532220 | Outbreak of West Nile virus causing severe neurological involvement in children, Nuba Mountains, Sudan, 2002. |
| Q40571643 | Outcome of West Nile fever in older adults |
| Q27477543 | Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion |
| Q40178607 | Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies |
| Q27481425 | Persistence of West Nile Virus-Specific Antibodies in Viremic Blood Donors |
| Q99565499 | Post-infectious neurological disorders |
| Q27487329 | Predictive spatial models for risk of West Nile virus exposure in eastern and western Colorado |
| Q27472851 | Real-time PCR in clinical microbiology: applications for routine laboratory testing |
| Q21284433 | Recent progress in West Nile virus diagnosis and vaccination |
| Q64134963 | Reemergence of West Nile Virus Infections in Southern Greece, 2017 |
| Q36411126 | Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis |
| Q34780434 | Response of the clinical microbiology laboratory to emerging (new) and reemerging infectious diseases |
| Q27485229 | Risk factors associated with human infection during the 2006 West Nile virus outbreak in Davis, a residential community in northern California |
| Q37082586 | Risk factors for West Nile virus infection and disease in populations and individuals |
| Q27485896 | Role of Nonstructural Protein NS2A in Flavivirus Assembly |
| Q33876476 | Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus. |
| Q40529444 | Screening for West Nile virus in organ transplantation: a medical decision analysis |
| Q40487525 | Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors |
| Q36393432 | Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signaling |
| Q90205634 | Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease |
| Q27482005 | Serological studies of West Nile virus in a liver transplant population |
| Q24570889 | Seroprevalence of West Nile Virus specific IgG and IgM antibodies in North-Western and Western provinces of Zambia |
| Q35030416 | Seroprevalence screening for the West Nile virus in Malaysia's Orang Asli population. |
| Q27487069 | Severe meningo-encephalitis and death in a renal transplant recipient resulting from West Nile virus infection |
| Q43046594 | Southern California neuroinvasive West Nile virus case series |
| Q40470085 | Stroke associated with central nervous system vasculitis after West Nile virus infection. |
| Q27469790 | Surveillance of above- and below-ground mosquito breeding habitats in a rural midwestern community: baseline data for larvicidal control measures against West Nile Virus vectors |
| Q40389342 | The effect of West Nile virus perceptions and knowledge on protective behavior and mosquito breeding in residential yards in upstate New York. |
| Q40317258 | The mosquito Aedes (Aedimorphus) vexans arabiensis as a probable vector bridging the West Nile virus between birds and horses in Barkedji (Ferlo, Senegal). |
| Q35211686 | The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis |
| Q27490872 | Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates |
| Q40061942 | Transcriptomic Analyses Reveal Differential Gene Expression of Immune and Cell Death Pathways in the Brains of Mice Infected with West Nile Virus and Chikungunya Virus |
| Q35180147 | Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectives |
| Q43046915 | Transient parkinsonism in West Nile virus encephalitis |
| Q40248549 | Transmission dynamics of West Nile virus in mosquitoes and corvids and non-corvids |
| Q27485255 | Transmission of Tropical and Geographically Restricted Infections during Solid-Organ Transplantation |
| Q40550030 | Transmission of West Nile Virus through Blood Transfusion in the United States in 2002 |
| Q45520511 | Transmission of West Nile virus by organ transplantation |
| Q40556726 | Urinary retention in a patient with West Nile virus |
| Q40514804 | Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases |
| Q40470435 | Utility of the focus technologies west nile virus immunoglobulin M capture enzyme-linked immunosorbent assay for testing cerebrospinal fluid. |
| Q40428683 | Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine |
| Q24570066 | Virus and antibody dynamics in acute west nile virus infection |
| Q27488431 | West Nile Virus Capsid Degradation of Claudin Proteins Disrupts Epithelial Barrier Function |
| Q27472821 | West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection |
| Q38880775 | West Nile Virus Encephalitis |
| Q40228190 | West Nile Virus Infection in the Immunocompromised Patient |
| Q40549578 | West Nile Virus-Associated Meningoencephalitis in Two Chronically Immunosuppressed Renal Transplant Recipients |
| Q26865618 | West Nile Virus: biology, transmission, and human infection |
| Q40489557 | West Nile chorioretinitis |
| Q27469711 | West Nile encephalitis |
| Q35549286 | West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review |
| Q54615771 | West Nile infections in pediatric solid organ transplant recipients. |
| Q40568456 | West Nile poliomyelitis |
| Q27473568 | West Nile virus |
| Q56932479 | West Nile virus |
| Q27482002 | West Nile virus - Mosquitoes no longer just an annoyance! |
| Q27490508 | West Nile virus - Mosquitoes no longer just an annoyance! |
| Q45404475 | West Nile virus -- Canada's index case. |
| Q40429246 | West Nile virus and blood product safety in Germany |
| Q40519491 | West Nile virus blood transfusion-related infection despite nucleic acid testing |
| Q40548182 | West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation |
| Q21563617 | West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior |
| Q38614147 | West Nile virus in Ontario, Canada: A twelve-year analysis of human case prevalence, mosquito surveillance, and climate data |
| Q40554292 | West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivation |
| Q40483723 | West Nile virus induced vocal fold paralysis |
| Q27469441 | West Nile virus infection and its neurological manifestations |
| Q27473563 | West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario |
| Q40290912 | West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic |
| Q35159163 | West Nile virus infection induces depletion of IFNAR1 protein levels |
| Q40554302 | West Nile virus infection transmitted by blood transfusion |
| Q35182679 | West Nile virus infection. What you need to know about this emerging threat |
| Q31041026 | West Nile virus infections projected from blood donor screening data, United States, 2003 |
| Q40509787 | West Nile virus meningitis in a chronic immunosuppressed patient with rheumatoid arthritis |
| Q37434776 | West Nile virus state of the art report of MALWEST Project |
| Q27481984 | West Nile virus surveillance and diagnostics: A Canadian perspective |
| Q40518547 | West Nile virus, an emerging arbovirus |
| Q34279673 | West Nile virus-associated optic neuritis and chorioretinitis |
| Q27473254 | West Nile virus. Update for family physicians |
| Q36396283 | West Nile virus: a challenge for transplant programs |
| Q35746093 | West Nile virus: a growing concern? |
| Q36061443 | West Nile virus: a primer for the otolaryngologist |
| Q35625021 | West Nile virus: epidemiology and ecology in North America |
| Q35214323 | West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention |
| Q35261421 | West Nile virus: immunity and pathogenesis |
| Q36733137 | West Nile virus: recent trends in diagnosis and vaccine development |
| Q36807273 | West Nile virus: strategies for predicting municipal-level infection. |
| Q35874060 | West Nile virus: where are we now? |
| Q40555981 | West nile epidemic in louisiana in 2002. |
| Q35036664 | West nile virus: current perspectives. |
| Q34630025 | Whole genome phylogenetic investigation of a West Nile virus strain isolated from a tick sampled from livestock in north eastern Kenya |
| Q24261184 | Zika Virus: Medical Countermeasure Development Challenges |
Search more.